Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 250

Posts Tagged ‘insulet’

Insulet to Present at Upcoming Investor Conferences

Posted by fidest press agency su domenica, 10 novembre 2019

The 2019 Stephens Nashville Investment Conference in Nashville, TN on Wednesday, November 13, 2019, at 10:30 a.m. (Central Time). The Piper Jaffray 31st Annual Healthcare Conference in New York City, NY on Wednesday, December 4, 2019, at 9:00 a.m. (Eastern Time). Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at two upcoming investor conferences.
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: and

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Insulet Partners with the International Diabetes Federation Europe to Support Advocacy Activities Across the Continent

Posted by fidest press agency su mercoledì, 11 luglio 2018

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced it has entered into a partnership with the European Region of the International Diabetes Federation (IDF Europe) to collaborate on regional advocacy activities. This partnership provides broader access for Insulet to more closely engage with the European diabetes community.“We are delighted to partner with IDF Europe, which represents 71 national diabetes organizations in 46 countries across Europe,” said DJ Cass, General Manager, Insulet Europe. “Through its advocacy work, IDF Europe’s mission is to improve the health outcomes of its 570,000 members and we look forward to working more closely with them through this powerful collaboration starting with the Youth Leadership Camp in the Czech Republic.” The Youth Leadership Camp is an annual event organized by IDF Europe to provide a unique experience for young people with diabetes to learn skills to become ambassadors for change, while sharing knowledge and interacting with their peers from multiple countries. The 8th edition of the IDF Europe Youth Leadership Camp is taking place in the Czech Republic, July 8-14, 2018.“There are one million people living with Type 1 Diabetes in Europe and IDF welcomes the support of key industry partners, such as Insulet, so we can work together to advocate for improved diabetes care,” said Prof. Dr. Sehnaz Karadeniz, Chair, IDF Europe Region. “The corporate panel at our Youth Leadership Camp is always well received by participants and we look forward to another interactive session this year. IDF Europe values the essential role youths play in raising diabetes awareness as they represent the voices of the future and we encourage them to play an active role advocating for change.” Insulet’s partnership with IDF Europe will also include joint activities for World Diabetes Day on November 14, 2018 and several additional advocacy activities throughout the year to increase recognition for the diabetes community and to support policy change.

Posted in Estero/world news, Uncategorized | Contrassegnato da tag: , , | Leave a Comment »

Insulet Achieves Key Milestones to Support its Transition to Direct Operations in Europe on July 1, 2018

Posted by fidest press agency su lunedì, 7 maggio 2018

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that it has achieved key milestones as it transitions to direct operations in Europe on July 1st. The Company has established a highly-talented European commercial team with deep knowledge of the diabetes landscape and extensive experience within the local markets. In addition, Insulet has partnered with two well respected and experienced companies – Teleperformance and HealthLink Europe – which will provide the full breadth of Insulet’s customer care, product support, distribution and logistics services.“We are excited about the significant progress we have made building an incredibly talented and knowledgeable team and strong partnerships to support our Omnipod users and healthcare professionals in Europe,” said Shacey Petrovic, President and Chief Operating Officer. “We are laser-focused on continuity of care and a seamless transition and I have full confidence this team will deliver best-in-class support for our European customers starting July 1st.” Teleperformance is the worldwide leader in outsourced customer care management and will manage Insulet’s Customer Care services across Europe. HealthLink Europe is a highly experienced healthcare and medical device third-party logistics provider and will manage Insulet’s product distribution throughout Europe.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »